WPD Pharmaceuticals Resumes Trading, Eyes Growth
Company Announcements

WPD Pharmaceuticals Resumes Trading, Eyes Growth

WPD Pharmaceuticals (TSE:WBIO) has released an update.

WPD Pharmaceuticals Inc. has resumed trading of its common shares on the Canadian Securities Exchange under the symbol ‘WBIO’ after transitioning to a minority shareholder position in its former subsidiary, WPD Pharmaceuticals Sp. z o.o., now WPD Pharmaceuticals S.A. The company is currently seeking additional capital to invest in or acquire businesses, aiming to create shareholder value through strategic partnerships and initiatives in the biotechnology field. An upcoming annual general meeting is scheduled for August 7, 2024, where shareholders will vote on various company matters.

For further insights into TSE:WBIO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskWPD Pharmaceuticals Restructures and Settles Debt
TipRanks Canadian Auto-Generated NewsdeskWPD Pharmaceuticals Converts Debt to Equity
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!